Luke M Beshar - Net Worth and Insider Trading

Luke M Beshar Net Worth

The estimated net worth of Luke M Beshar is at least $594,000 dollars as of 2024-05-11. Luke M Beshar is the Director of Protara Therapeutics Inc and owns about 198,000 shares of Protara Therapeutics Inc (TARA) stock worth over $594,000. Luke M Beshar is also the Director of Regenxbio Inc and owns about 0 shares of Regenxbio Inc (RGNX) stock worth over $0. Details can be seen in Luke M Beshar's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Luke M Beshar has not made any transactions after 2022-06-30 and currently still holds the listed stock(s).

Transaction Summary of Luke M Beshar

To

Luke M Beshar Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Luke M Beshar owns 3 companies in total, including Protara Therapeutics Inc (TARA) , Regenxbio Inc (RGNX) , and Omega Therapeutics Inc (OMGA) .

Click here to see the complete history of Luke M Beshar’s form 4 insider trades.

Insider Ownership Summary of Luke M Beshar

Ticker Comapny Transaction Date Type of Owner
TARA Protara Therapeutics Inc 2022-06-30 director
RGNX Regenxbio Inc 2018-11-29 director
OMGA Omega Therapeutics Inc 2021-07-29 director

Luke M Beshar Latest Holdings Summary

Luke M Beshar currently owns a total of 2 stocks. Among these stocks, Luke M Beshar owns 198,000 shares of Protara Therapeutics Inc (TARA) as of June 30, 2022, with a value of $594,000 and a weighting of 100%. Luke M Beshar also owns 0 shares of Regenxbio Inc (RGNX) as of November 29, 2018, with a value of $0 and a weighting of 0%.

Latest Holdings of Luke M Beshar

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TARA Protara Therapeutics Inc 2022-06-30 198,000 3.00 594,000
RGNX Regenxbio Inc 2018-11-29 0 15.44 0

Holding Weightings of Luke M Beshar


Luke M Beshar Form 4 Trading Tracker

According to the SEC Form 4 filings, Luke M Beshar has made a total of 3 transactions in Protara Therapeutics Inc (TARA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Protara Therapeutics Inc is the acquisition of 10,000 shares on June 30, 2022, which cost Luke M Beshar around $31,000.

According to the SEC Form 4 filings, Luke M Beshar has made a total of 0 transactions in Regenxbio Inc (RGNX) over the past 5 years. The most-recent trade in Regenxbio Inc is the sale of 12,784 shares on November 29, 2018, which brought Luke M Beshar around $830,960.

Insider Trading History of Luke M Beshar

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Luke M Beshar Trading Performance

GuruFocus tracks the stock performance after each of Luke M Beshar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Luke M Beshar is -17.58%. GuruFocus also compares Luke M Beshar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Luke M Beshar within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Luke M Beshar's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Luke M Beshar

Average Return

Average return per transaction

Outperforming Transactions

0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.21
Relative Return to S&P 500(%) 1.63

Luke M Beshar Ownership Network

Ownership Network List of Luke M Beshar

No Data

Ownership Network Relation of Luke M Beshar


Luke M Beshar Owned Company Details

What does Protara Therapeutics Inc do?

Who are the key executives at Protara Therapeutics Inc?

Luke M Beshar is the director of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include 10 percent owner Opaleye Management Inc. , Chief Financial Officer Patrick Fabbio , and director & CEO and President Jesse Shefferman .

Protara Therapeutics Inc (TARA) Insider Trades Summary

Over the past 18 months, Luke M Beshar made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 197,773 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 182,300 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 182,300 shares. During the past 18 months, 197,773 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 197,773 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Protara Therapeutics Inc Insider Transactions

No Available Data

Luke M Beshar Mailing Address

Above is the net worth, insider trading, and ownership report for Luke M Beshar. You might contact Luke M Beshar via mailing address: 550 Hills Drive, 3rd Floor, Bedminster Nj 07921.

Discussions on Luke M Beshar

No discussions yet.